Home
/
cbdMD, Inc.
/
Financials
/
Quarterly
cbdMD, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that cbdMD, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Dec 31, 2025
$5.02M
Feb 17, 2026
Q3
2025
Jun 30, 2025
$4.61M
Aug 14, 2025
Q2
2025
Mar 31, 2025
$4.75M
May 15, 2025
Q1
2025
Dec 31, 2024
$5.11M
Feb 17, 2026
Q3
2025
Jun 30, 2024
$5.17M
Aug 14, 2025
Q2
2025
Mar 31, 2024
$4.38M
May 15, 2025
Q1
2025
Dec 31, 2023
$5.38M
Feb 13, 2025
Q3
2024
Jun 30, 2023
$6.12M
Aug 14, 2024
Q2
2024
Mar 31, 2023
$6.24M
May 15, 2024
Q1
2024
Dec 31, 2022
$6.09M
Feb 13, 2024
Q3
2023
Jun 30, 2022
$8.59M
Aug 10, 2023
Q2
2023
Mar 31, 2022
$9.63M
May 15, 2023
Q1
2023
Dec 31, 2021
$9.32M
Feb 13, 2023
Q3
2022
Jun 30, 2021
$10.56M
Aug 11, 2022
Q2
2022
Mar 31, 2021
$11.80M
May 13, 2022
Q1
2022
Dec 31, 2020
$12.33M
Feb 10, 2022
Q3
2021
Jun 30, 2020
$10.64M
Aug 12, 2021
Q2
2021
Mar 31, 2020
$9.40M
May 12, 2021
Q1
2021
Dec 31, 2019
$10.15M
Feb 9, 2021
Q3
2020
Jun 30, 2019
$8.01M
Aug 12, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Mar 31, 2018
$3.03M
May 15, 2018
Q1
2018
Dec 31, 2017
$433.2K
Feb 14, 2018
Q2
2018
Mar 31, 2017
$1.14M
May 15, 2018
Q1
2018
Dec 31, 2016
$199.8K
Feb 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Dec 31, 2025
($283.1K)
Feb 17, 2026
Q3
2025
Jun 30, 2025
($895.3K)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($480.8K)
May 15, 2025
Q3
2025
Mar 31, 2025
($480.8K)
Aug 14, 2025
Q2
2025
Dec 31, 2024
$15.1K
May 15, 2025
Q3
2025
Dec 31, 2024
$15.1K
Aug 14, 2025
Q1
2025
Dec 31, 2024
$15.1K
Feb 17, 2026
Q3
2025
Jun 30, 2024
$459.7K
Aug 14, 2025
Q3
2025
Mar 31, 2024
($3.01M)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($3.01M)
May 15, 2025
Q3
2025
Dec 31, 2023
($996.5K)
Aug 14, 2025
Q2
2025
Dec 31, 2023
($996.5K)
May 15, 2025
Q1
2025
Dec 31, 2023
($996.5K)
Feb 13, 2025
Q3
2024
Jun 30, 2023
($1.77M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($1.34M)
May 15, 2024
Q3
2024
Mar 31, 2023
($1.34M)
Aug 14, 2024
Q2
2024
Dec 31, 2022
($3.96M)
May 15, 2024
Q1
2024
Dec 31, 2022
($3.96M)
Feb 13, 2024
Q3
2024
Dec 31, 2022
($3.96M)
Aug 14, 2024
Q3
2023
Jun 30, 2022
($31.63M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Dec 31, 2025
($286.3K)
Feb 17, 2026
Q3
2025
Jun 30, 2025
($904.7K)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($485.8K)
May 15, 2025
Q1
2025
Dec 31, 2024
($86.3K)
Feb 17, 2026
Q3
2025
Jun 30, 2024
($382.0K)
Aug 14, 2025
Q2
2025
Mar 31, 2024
($1.55M)
May 15, 2025
Q1
2025
Dec 31, 2023
($1.07M)
Feb 13, 2025
Q3
2024
Jun 30, 2023
($1.82M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($1.40M)
May 15, 2024
Q1
2024
Dec 31, 2022
($4.05M)
Feb 13, 2024
Q3
2023
Jun 30, 2022
($33.13M)
Aug 10, 2023
Q2
2023
Mar 31, 2022
($5.01M)
May 15, 2023
Q1
2023
Dec 31, 2021
($25.15M)
Feb 13, 2023
Q3
2022
Jun 30, 2021
($6.68M)
Aug 11, 2022
Q2
2022
Mar 31, 2021
($4.17M)
May 13, 2022
Q1
2022
Dec 31, 2020
($1.76M)
Feb 10, 2022
Q3
2021
Jun 30, 2020
($1.34M)
Aug 12, 2021
Q2
2021
Mar 31, 2020
($5.60M)
May 12, 2021
Q1
2021
Dec 31, 2019
($6.11M)
Feb 9, 2021
Q3
2020
Jun 30, 2019
($6.47M)
Aug 12, 2020